相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The blood-brain barrier fatty acid transport protein 1 (FATP1/SLC27A1) supplies docosahexaenoic acid to the brain, and insulin facilitates transport
Yusuke Ochiai et al.
JOURNAL OF NEUROCHEMISTRY (2017)
The blood-brain barrier and protein-mediated fatty acid uptake: role of the blood-brain barrier as a metabolic barrier An Editorial Comment for 'The blood-brain barrier fatty acid transport protein 1 (FATP1/SLC27A1) supplies docosahexaenoic acid to the brain, and insulin facilitates transport'
Eric J. Murphy
JOURNAL OF NEUROCHEMISTRY (2017)
Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder
Jingshu Xu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function
Yijun Pan et al.
JOURNAL OF NEUROSCIENCE (2016)
Fatty Acid Binding Protein 5 Modulates Docosahexaenoic Acid-Induced Recovery in Rats Undergoing Spinal Cord Injury
Johnny D. Figueroa et al.
JOURNAL OF NEUROTRAUMA (2016)
Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis
Hussein N. Yassine et al.
JAMA NEUROLOGY (2016)
Fatty Acid-Binding Protein 5 Facilitates the Blood-Brain Barrier Transport of Docosahexaenoic Acid
Yijun Pan et al.
MOLECULAR PHARMACEUTICS (2015)
Alpha Adrenergic Induction of Transport of Lysosomal Enzyme across the Blood-Brain Barrier
Akihiko Urayama et al.
PLoS One (2015)
Plasma non-esterified docosahexaenoic acid is the major pool supplying the brain
Chuck T. Chen et al.
SCIENTIFIC REPORTS (2015)
Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer's Disease
J. Thomas et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Comprehensive Profiling of Plasma Fatty Acid Concentrations in Young Healthy Canadian Adults
Salma A. Abdelmagid et al.
PLOS ONE (2015)
Fatty Acid-binding Protein 5 (FABP5) Regulates Cognitive Function Both by Decreasing Anandamide Levels and by Activating the Nuclear Receptor Peroxisome Proliferatoractivated Receptor β/δ(PPARβ/δ) in the Brain
Shuiliang Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid
Long N. Nguyen et al.
NATURE (2014)
Reduced CNS exposure of memantine in a triple transgenic mouse model of Alzheimer's disease assessed using a novel LC-MS technique
Dharmini C. Mehta et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2013)
Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease
Kenghoe Lok et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Altered Brain Uptake of Therapeutics in a Triple Transgenic Mouse Model of Alzheimer's Disease
Dharmini C. Mehta et al.
PHARMACEUTICAL RESEARCH (2013)
Cognitive Enhancement with Rosiglitazone Links the Hippocampal PPARγ and ERK MAPK Signaling Pathways
Larry A. Denner et al.
JOURNAL OF NEUROSCIENCE (2012)
The novel object recognition memory: neurobiology, test procedure, and its modifications
M. Antunes et al.
COGNITIVE PROCESSING (2012)
Omega-3 Polyunsaturated Fatty Acids in Alzheimer's Disease: Key Questions and Partial Answers
F. Calon
CURRENT ALZHEIMER RESEARCH (2011)
Impact and Therapeutic Potential of PPARs in Alzheimers Disease
Michael T. Heneka et al.
Current Neuropharmacology (2011)
Docosahexaenoic Acid-Derived Neuroprotectin D1 Induces Neuronal Survival via Secretase- and PPARγ-Mediated Mechanisms in Alzheimer's Disease Models
Yuhai Zhao et al.
PLOS ONE (2011)
Phosphatidylserine-dependent neuroprotective signaling promoted by docosahexaenoic acid
Hee-Yong Kim et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2010)
Effects of the Endogenous PPAR-α Agonist, Oleoylethanolamide on MDMA-Induced Cognitive Deficits in Mice
Ainhoa Plaza-Zabala et al.
SYNAPSE (2010)
Validation of a 2-day water maze protocol in mice
Maria Gulinello et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study
Melissa Ouellet et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
HIGH DIETARY CONSUMPTION OF TRANS FATTY ACIDS DECREASES BRAIN DOCOSAHEXAENOIC ACID BUT DOES NOT ALTER AMYLOID-β AND TAU PATHOLOGIES IN THE 3xTg-AD MODEL OF ALZHEIMER'S DISEASE
A. Phivilay et al.
NEUROSCIENCE (2009)
Low-temperature improved-throughput method for analysis of brain fatty acids and assessment of their post-mortem stability
Thomas Fraser et al.
JOURNAL OF NEUROSCIENCE METHODS (2008)
Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood-brain barrier
William A. Banks et al.
PEPTIDES (2008)
Regulation of brain polyunsaturated fatty acid uptake and turnover
Chuck T. Chen et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2008)
Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver
Stanley I. Rapoport et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2007)
Lipid metabolism in Alzheimer's and Parkinson's disease
Qin Xu et al.
FUTURE LIPIDOLOGY (2006)
Pathophysiology of Alzheimer's disease
BP Imbimbo et al.
NEUROIMAGING CLINICS OF NORTH AMERICA (2005)
A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease
WJ Lukiw et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease
F Calon et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Gender differences in the amount and deposition of amyloid beta in APPswe and PS1 double transgenic mice
J Wang et al.
NEUROBIOLOGY OF DISEASE (2003)
分享论文
